|Bid||94.43 x 800|
|Ask||94.44 x 1200|
|Day's Range||93.34 - 94.45|
|52 Week Range||81.18 - 94.45|
|PE Ratio (TTM)||16.87|
|Dividend & Yield||2.76 (2.96%)|
|1y Target Est||N/A|
The consumer product giant unveiled the homework it has done on Peltz, who is engaged in proxy fight for a board seat.
Procter & Gamble released a hefty report taking aim at Trian Fund Management's uneven history of delivering results, escalating the proxy fight between the consumer product giant and Nelson Peltz's firm. Trian disclosed its stake in P&G (PG) February in a filing with the Securities & Exchange Commission and Peltz requested a seat on the company's board privately (P&G declined), and then, publicly in July. Peltz laid out his case in a 94-page presentation early September.
Blue chips were mostly up, but gains were restrained. Procter & Gamble was one of the Dow's top gainers.